Topic
Cannabis hyperemesis syndrome
💡 What You Need to Know
- Definition: Cannabis Hyperemesis Syndrome (CHS) is a condition affecting chronic cannabis users, characterized by cyclical episodes of severe nausea, intractable vomiting, and abdominal pain.
- Key Feature: Symptoms typically resolve completely and permanently with sustained cessation of all cannabis products.
- Misdiagnosis Risk: Often mistaken for Cyclic Vomiting Syndrome (CVS) or other gastrointestinal disorders due to similar symptom presentation.
- Prevalence: Increasing with the rising potency and frequency of cannabis use.
🤒 Associated Symptoms
- Prodromal Phase: Early morning nausea, abdominal discomfort, and a fear of vomiting, often leading to increased cannabis use in an attempt to alleviate symptoms.
- Hyperemetic Phase: Intense, persistent nausea, severe and often intractable vomiting, and diffuse abdominal pain.
- Compulsive Hot Bathing/Showering: A hallmark symptom where patients find temporary relief from nausea and pain by taking frequent hot baths or showers.
- Dehydration: Significant fluid loss due to persistent vomiting, potentially leading to electrolyte imbalances.
- Weight Loss: Chronic nausea and vomiting can lead to unintentional weight loss over time.
🛡 Crucial Precautions
- Cannabis Cessation: The most critical precaution and the only definitive treatment; complete abstinence from all cannabis products (THC, CBD, edibles, concentrates) is essential.
- Avoid Triggers: Any reintroduction of cannabis, even after a period of abstinence, can trigger a relapse of symptoms.
- Hydration Management: Vigilant monitoring and management of hydration status during acute episodes to prevent severe dehydration and electrolyte disturbances.
- Medical Evaluation: Seek prompt medical attention for severe vomiting, abdominal pain, or signs of dehydration to rule out other serious conditions.
- Complication Awareness: Be aware of potential complications such as esophageal tears (Mallory-Weiss syndrome), acute kidney injury, and electrolyte abnormalities.
🍽 Dietary Directions & Restrictions
- Acute Phase: Initially, maintain NPO (nil per os) status to rest the gastrointestinal tract, then gradually reintroduce clear liquids.
- Bland Diet Progression: As tolerated, advance to a bland, low-fat diet, avoiding foods that may irritate the stomach.
- Avoid Irritants: Strictly avoid spicy, fatty, acidic foods, caffeine, alcohol, and any other known gastrointestinal irritants.
- Small, Frequent Meals: Once able to tolerate solids, consume small, frequent meals to minimize gastric distension and nausea.
- Oral Rehydration: Utilize oral rehydration solutions to replenish fluids and electrolytes once vomiting subsides.
⚠️ Attendant Guidelines
- Patient Education: Provide clear and empathetic education linking chronic cannabis use to the patient's symptoms and emphasizing the necessity of abstinence.
- Symptom Management: Administer antiemetics (often ineffective), benzodiazepines (for anxiety and nausea), and consider topical capsaicin cream for abdominal pain relief.
- Electrolyte Monitoring: Closely monitor serum electrolytes, especially potassium, sodium, and chloride, and correct imbalances promptly.
- Support for Cessation: Offer resources and referrals for cannabis use disorder treatment and psychological support to aid in sustained abstinence.
- Environmental Control: Create a calm, quiet environment for the patient during acute episodes to minimize sensory stimulation.
🩺 Physician's Perspective
- Comprehensive History: A detailed history of cannabis use, including frequency, duration, and type, is paramount for accurate diagnosis.
- Differential Diagnosis: Carefully differentiate CHS from other causes of cyclic vomiting, such as Cyclic Vomiting Syndrome, gastroparesis, and other gastrointestinal pathologies.
- Treatment Strategy: The cornerstone of treatment is complete cannabis cessation, supported by symptomatic management during acute phases.
- Pharmacological Approach: While traditional antiemetics are often ineffective, benzodiazepines, haloperidol, and topical capsaicin have shown some utility in managing acute symptoms.
- Long-term Management: Emphasize the importance of long-term abstinence and consider referral to addiction specialists for ongoing support and relapse prevention.
🎓 Academic & Nursing Corner
- Assessment Focus: Conduct a thorough assessment including a detailed substance use history, symptom characteristics (onset, duration, relieving factors like hot showers), and hydration status.
- Nursing Interventions: Administer IV fluids as prescribed, monitor intake and output, provide antiemetics and pain relief, and ensure a safe, comfortable environment.
- Patient Teaching: Educate patients on the direct link between cannabis and their symptoms, the importance of abstinence, and strategies for managing withdrawal symptoms.
- Psychosocial Support: Recognize the potential for underlying substance use disorder and provide empathetic support, offering resources for counseling and support groups.
- Electrolyte Balance: Closely monitor laboratory results for electrolyte imbalances and report critical values to the physician promptly.
🔬 Clinical Reference Index
- Pathophysiology: The exact mechanism is unclear but is thought to involve dysregulation of cannabinoid receptors (CB1, CB2) in the central nervous system and enteric nervous system, affecting thermoregulation and emetic centers.
- Diagnostic Criteria: Clinical diagnosis based on chronic cannabis use, cyclical episodes of nausea and vomiting, abdominal pain, compulsive hot bathing, and resolution of symptoms with cannabis cessation.
- Pharmacology: Antiemetics (e.g., ondansetron, metoclopramide) are often ineffective. Benzodiazepines (e.g., lorazepam) can help with anxiety and nausea. Haloperidol has shown efficacy in refractory cases. Topical capsaicin cream may provide localized relief.
- Epidemiology: Predominantly affects long-term, heavy cannabis users, with an increasing incidence observed in emergency departments.
- Differential Diagnosis: Key conditions to rule out include Cyclic Vomiting Syndrome, gastroparesis, peptic ulcer disease, gastroenteritis, and acute abdomen.